Return to Results

Coral: Cardiovascular Outcomes in Renal Atherosclerotic Lesions Randomized and Multi-Center Two-Group Clinical Trial to Assess the Best Treatment for Patients with High Blood Pressure and Renal Artery

new search

Trial Conditions
  • Renal Artery Stenosis
What is the purpose of this trial?

A prospective, multi-center, unblended, two-arm, randomized trial. Designed to test the hypothesis that medical therapy with stenting of significant renal artery stenosis in patients with systolic hypertension reduces the incidence of adverse cardiovascular and renal events compared with medical therapy alone. The study will enroll patients with a history of systolic hypertension, who have documented renal artery stenosis. Patients will be randomized via several pathways to either medical therapy or medical therapy and with renal artery stenting and be closely monitored for blood pressure control and management of other risk factors.

Date & Status



Patients 18 and older with a documented history of hypertension and/or chronic kidney disease with a GFR <60 cc/min who are suspected to have renal artery stenosis.  Patients on 2 or more anti-hypertensive medications.  Severe renal artery stenosis of 60%-99% by angiogram, duplex systolic velocity of 300cm/sec or MRA documenting >80% stenosis.

Steward Physician(s)
  • St. Elizabeth's Medical Center - Recruiting
Physician Researcher

Physician Name/s:

  • Lawrence  Alexander Garcia MD
  • Other Information

    Sponsor: HCRI
    Trial ID: Renal Artery Stenosis
    Volunteers:  Not Accepting Healthy Volunteers

    new search

    Connect with Steward

    Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

    Subscribe to our patient e-newsletter

    Copyright © 2015 Steward Health Care
    Connect Healthcare Panacea CMS Solutions